(Q63816440)
Statements
A Phase Ib/II, Multicenter, Randomized, Single-Masked, Sham Injection-Controlled Study of Safety, Tolerability, and Evidence of Activity of FCFD4514S Intravitreal Injections Administered Monthly or Every Other Month to Patients With Geographic Atrophy (English)
0 references
February 2011
0 references
April 2013
0 references
143
0 references
60 year
0 references
89 year
0 references